Early in the disease (prediabetes or new‐onset T2D), hepatic IR and compensatory hyperinsulinemia maintain normoglycemia, prompting β‐cell hyperplasia, an adaptive response to the increased insulin demand. The gene discussed is INS; the disease is type 2 diabetes mellitus.